Literature DB >> 31876885

MANAGEMENT OF REFRACTORY LARGE MACULAR HOLE WITH AUTOLOGOUS NEUROSENSORY RETINAL FREE FLAP TRANSPLANTATION.

Yo-Chen Chang1,2,3, Pei-Kang Liu3, Tzu-En Kao3,4, Kuo-Jen Chen5, Yi-Hsien Chen3, Wei-Jun Chiu3, Kwou-Yeung Wu2,3, Wen-Chuan Wu2,3.   

Abstract

PURPOSE: To investigate the morphological and functional outcome of refractory large macular hole (MH) with autologous neurosensory retinal free flap transplantation.
METHODS: This case series enrolled 10 patients suffering from refractory large MH at Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. All eyes underwent pars plana vitrectomy, a neurosensory retinal free flap with a 1.5 to 2-MH diameter was harvested. We used an adhesive agent such as whole blood or Viscoat to assist the stabilization of the retinal free flap and then use tamponade silicone oil to tamponade the vitreous cavity. Silicone oil was removed 6 months postoperatively. Main outcome measures including closure of MH and change in best-corrected visual acuity change were recorded.
RESULTS: The mean age was 64.9 ± 11.5 years. Before presentation, all cases had received at least two vitreoretinal procedures including vitrectomy, internal limiting membrane peeling, and fluid-gas exchange. At last visit, closure of the MH was achieved in 9 of 10 (90%) cases. The mean preoperative best-corrected visual acuity and that after 12 months of surgery improved from 1.65 ± 0.43 logarithm of minimum angle of resolution to 0.88 ± 0.49 logarithm of minimum angle of resolution (P < 0.001).
CONCLUSION: For eyes with refractory or large MH, autologous neurosensory retinal free flap under silicone oil tamponade may provide a new option to improve the anatomical and function outcome, especially in cases where insufficient internal limiting membrane is left.

Entities:  

Year:  2020        PMID: 31876885     DOI: 10.1097/IAE.0000000000002734

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  A retrospective, multicenter study on the management of macular holes without residual internal limiting membrane: the refractory macular hole (ReMaHo) study.

Authors:  Umberto Lorenzi; Joel Mehech; Tommaso Caporossi; Mario R Romano; Rocco De Fazio; Eric Parrat; Frédéric Matonti; Paolo Mora
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-06       Impact factor: 3.117

2.  Secondary Vitrectomy with Internal Limiting Membrane Plug due to Persistent Full-Thickness Macular Hole OCT-Angiography and Microperimetry Features: Case Series.

Authors:  Dominika Wrzesińska; Katarzyna Nowomiejska; Dominika Nowakowska; Mario Damiano Toro; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Robert Rejdak
Journal:  J Ophthalmol       Date:  2020-09-21       Impact factor: 1.909

3.  Long-Term Follow-Up of Refractory Large Macular Hole with Autologous Neurosensory Retinal Free Flap Transplantation.

Authors:  Po-Yen Lee; Yo-Chen Chang; Pei-Kang Liu; Tzu-En Kao; Horng-Jiun Wu; Kuo-Jen Chen; Kwou-Yeung Wu; Kai-Chun Cheng; Wen-Chuan Wu
Journal:  J Ophthalmol       Date:  2022-05-09       Impact factor: 1.974

4.  MANAGEMENT OF LARGE OR RECURRENT MACULAR HOLES.

Authors:  Hailey Kay Robles-Holmes; Patrick C Staropoli; Nicolas Yannuzzi; Jayanth Sridhar
Journal:  Curr Ophthalmol Rep       Date:  2020-04-30

5.  Functional evaluation with microperimetry in large idiopathic macular holes treated by a free internal limiting membrane flap tamponade technique.

Authors:  Peirong Huang; Hong Wang; Fenge Chen; Jieqiong Chen; Yifan Hu; Junran Sun; Jingyang Feng; Hong Zhu
Journal:  BMC Ophthalmol       Date:  2020-07-23       Impact factor: 2.209

Review 6.  Update on surgical management of complex macular holes: a review.

Authors:  Mohd-Asyraaf Abdul-Kadir; Lik Thai Lim
Journal:  Int J Retina Vitreous       Date:  2021-12-20

Review 7.  Refractory full thickness macular hole: current surgical management.

Authors:  Rino Frisina; Irene Gius; Luigi Tozzi; Edoardo Midena
Journal:  Eye (Lond)       Date:  2021-01-21       Impact factor: 4.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.